Shanghai Haohai Biological Technology Dividends and Buybacks
Dividend criteria checks 2/6
Shanghai Haohai Biological Technology is a dividend paying company with a current yield of 3.01% that is well covered by earnings.
Key information
3.0%
Dividend yield
1.5%
Buyback Yield
| Total Shareholder Yield | 4.5% |
| Future Dividend Yield | 4.1% |
| Dividend Growth | 12.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.873 |
| Payout ratio | 85% |
Recent dividend and buyback updates
Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 6826 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6826's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
| Shanghai Haohai Biological Technology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (6826) | 3.0% |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (6826) (up to 3 years) | 4.1% |
Notable Dividend: 6826's dividend (3.01%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.22%).
High Dividend: 6826's dividend (3.01%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.01%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (85.2%), 6826's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (56.8%), 6826's dividend payments are covered by cash flows.